Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of AJU-C716 Compared to C716R in Healthy Adult Volunteers
NCT07655960Phase 1Completed
- Sponsor
- AJU PHARM Co., Ltd.
- Start
- Jun 2026
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in hypercholesterolemia and dyslipidemia (2 arms), sponsored by AJU PHARM Co., Ltd. Primary endpoints: Area Under the Curve from time zero to the last quantifiable concentration and Maximum Observed Plasma Concentration. Started Jun 2026; status: completed.
02
Conditions
hypercholesterolemiadyslipidemia
Beyond the preview
Go deeper on NCT07655960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07655960.